Sustained-release PLGA-based nanoformulated solutions for drug delivery and targeting in paediatric solid and haematological malignancies
Pediatric brain tumors continue to be one of the leading causes of death among children due to cancer because of the inadequacies of existing treatments, which include poor tumor selectivity, poor permeability across the blood-brain barrier, resistance to treatment, and high levels of side effects on developing tissu...